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Abstract
Objectives—To assess the morbidity associated with continuing the second-stage duration of 
labor, weighing the probability of spontaneous vaginal birth without morbidity compared with 
birth with serious maternal or neonatal complications.
Methods—In a retrospective cohort, we analyzed singleton, vertex births ≥ 36 weeks of gestation 
without prior cesarean (n=43,810 nulliparous and 59,605 multiparous women). We calculated rates 
of spontaneous vaginal birth and composite serious maternal or neonatal complications. Results 
were stratified by parity (nulliparous or multiparous) and epidural status (yes or no). Competing 
risks models were created for: 1) spontaneous vaginal birth with no morbidity; 2) birth with 
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maternal or neonatal morbidity; and 3) no spontaneous vaginal birth and no morbidity, and our 
main interest was in comparing number 1 above against number 2.
Results—Rates of spontaneous vaginal birth without morbidity were slightly higher after the first 
half hour (>0.5 to 1.0 hour) for nulliparous women, after which rates decreased with increasing 
second-stage duration. For multiparous women, rates of spontaneous vaginal birth without 
morbidity decreased with increasing second-stage duration. For illustration, for a nulliparous 
woman with an epidural at 3.0 hours of second stage who extended by another 1.0 hour, her 
likelihood of delivering by spontaneous vaginal birth was 31.4% compared to her likelihood of 
birth with any serious complication in the next hour of 7.6%. The percent of cesareans for 
nonreassuring fetal heart rate tracing were higher for women without compared to with an 
epidural.
Conclusion—Rates of spontaneous vaginal birth without serious morbidity steadily decreased 
for increasing second-stage duration except for the first half hour for nulliparous women. We did 
not observe an inflection point at a particular hour mark for either spontaneous vaginal delivery 
without morbidity or births with morbidity. Our findings will assist in the decision making for 
extending second-stage duration.
Introduction
Prolonged second stage of labor beyond historical definitions is associated with high rates of 
successful vaginal birth but increased risks of maternal and neonatal morbidity.(1) 
Specifically, prolonging the second stage of labor is associated with increased maternal 
morbidity including postpartum hemorrhage, maternal febrile morbidity, infection and 
perineal trauma. There is also increased neonatal morbidity including increased rates of 5 
minute Apgar score < 4 (except nulliparous women without an epidural), neonatal intensive 
care unit (NICU) admission, neonatal asphyxia in nulliparous women, and perinatal 
mortality for deliveries without an epidural; however, the overall absolute rates for both of 
these latter outcomes are low (<0.5%).(1)
In a workshop including the Society for Maternal-Fetal Medicine and ACOG to prevent the 
first cesarean birth, it was recommended that second-stage arrest could be defined after an 
additional hour: four and three hours for nulliparous women with and without an epidural, 
respectively, and three and two hours for multiparous women with and without an epidural, 
respectively.(2) Clinical counseling and decision making requires weighing the likelihood of 
achieving vaginal birth with the risks of complications that can occur with increasing 
second-stage duration. Information on the risks of specific durations for second stage of 
labor is currently lacking.(3, 4) The aim of our study was to calculate the likelihood of 
vaginal birth without serious maternal or neonatal morbidity or mortality versus birth with 
morbidity or mortality to assist in clinical decision making.
Materials and Methods
This was a retrospective analysis utilizing the data from the Consortium on Safe Labor 
(CSL). The CSL was a retrospective study of electronic medical records from 12 U.S. sites, 
2002–2008, with a main study aim of determining the optimal time for operative birth 
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during the course of labor to minimize maternal and neonatal complications.(5) Data were 
abstracted from the electronic medical record including demographic, medical, prenatal, 
antenatal and labor and birth and neonatal information, and supplemented with maternal and 
newborn discharge summaries. Validation of four important variables was performed with 
manual chart review, including cesarean birth for nonreassuring fetal heart rate tracing, 
asphyxia, NICU admission for respiratory conditions and shoulder dystocia. The electronic 
medical records were demonstrated to be highly accurate with >91% concordance for all 
subgroups and >95% for most.(5, 6) Institutional Review Board approval was obtained by 
all participating institutions.
In the current study analysis, we included all women who delivered a singleton, vertex, non-
anomalous fetus ≥ 36 weeks of gestation. Women who had an antepartum stillbirth, prior 
uterine incision, or failed to reach the second stage of labor were excluded, for a total of 
n=43,810 nulliparous and 59,605 multiparous women remaining for present analysis. Details 
on the analytic cohort were previously published.(1)
Duration of the second stage of labor was calculated as the difference between the date and 
time of birth from the date and time of 10cm cervical dilation as recorded in the maternal 
medical record. Spontaneous vaginal birth was chosen as the reference group since operative 
vaginal and cesarean births are associated with increased maternal and neonatal morbidity.
When considering what would be the optimal duration of the second stage of labor, we 
considered any serious maternal or neonatal outcome as an event to be avoided. Therefore, 
an event was considered to have occurred if any of the outcomes were present. Maternal and 
neonatal outcomes were abstracted from the medical record. Composite maternal serious 
maternal complications included postpartum hemorrhage, blood transfusion, cesarean 
hysterectomy, intensive care unit (ICU) admission, or death. Composite neonatal serious 
complications included shoulder dystocia with fetal injury (clavicular fracture, Erb palsy, 
Klumpke palsy or hypoxic ischemic encephalopathy), need for continuous positive airway 
pressure (CPAP) resuscitation or higher, NICU length of stay > 72 hours, sepsis, pneumonia, 
hypoxic-ischemic encephalopathy or periventricular leukomalacia, seizure, intracranial 
hemorrhage or periventricular hemorrhage, asphyxia, or neonatal death.
Indications for cesarean birth were as recorded in the electronic medical record and mapped 
into predefined categories as previously described. (3)
The duration of second stage and rates of mode of birth (spontaneous vaginal, operative 
vaginal and cesarean birth) as well as rates of composite maternal and composite neonatal 
outcomes for deliveries were calculated for each parity (nulliparous or multiparous) and 
epidural status (yes or no). Rates were plotted for each 0.5-hour interval duration of second 
stage on bar graphs. The denominator included deliveries occurring during each 0.5-hour 
interval.
For remaining analyses, we estimated a composite complication for maternal and neonatal 
complications combined. We first estimated for a given duration of second stage of labor the 
additional probability that a woman would achieve a vaginal birth and how often morbidity 
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occurred during a subsequent time interval of 0.5 hours with additional duration of second 
stage beyond a certain time point.
For analysis, we treated duration of second stage of labor as competing risks type of data. 
Competing risks event are said to be present when a patient is at risk of more than one 
mutually exclusive event, such as death from different causes, and the occurrence of one of 
these events will prevent any other event from ever happening. We considered the following 
three exclusive outcomes during the second stage of labor: 1) spontaneous vaginal birth 
without maternal or neonatal serious morbidity or mortality; 2) birth by any mode with any 
maternal or neonatal serious morbidity or mortality; 3) non-spontaneous vaginal birth (i.e. 
operative vaginal or cesarean birth) without any maternal or neonatal serious morbidity or 
mortality. Note that in our analysis, our main interest was in comparing the 1) spontaneous 
vaginal birth with no morbidity against 2) deliveries with any morbidity, so we combined 
operative vaginal or cesarean birth with no morbidity as one cause. This technique does not 
change our probabilities for the main objectives. For example, if one were interested in risk 
of cancer deaths against not dying from cancer, other causes of death would be combined. 
We estimated the probabilities of delivering by spontaneous vaginal birth without serious 
morbidity or mortality and probabilities of delivering by any mode with any serious 
morbidity or mortality, during the next 0.5-hour interval given that the woman had not 
delivered by the current time point) based on a competing risks framework defined earlier. 
These probabilities are calculated as ratio of the probability of a birth of specific cause 
occurring in the interval of interest with that of probability of woman at risk of delivering at 
the start of the time interval. These probabilities are based on cumulative incidence functions 
and overall survival probability (i.e. probability of a woman still at risk for birth).(7) Rates 
for additional intervals were also calculated.
Indications for cesarean birth were calculated for extending the second stage of birth by one 
hour past historical definitions of second-stage duration for parity and epidural status.
All analyses were implemented using SAS (version 9.4, SAS Institute, Inc., Cary, North 
Carolina) or R (version 3.1.2, http://www.R-project.org).
Results
Nulliparous women incurred a serious maternal complication in 7.0% of cases with an 
epidural and 5.0% without an epidural, while multiparous women incurred a serious 
maternal complication in 6.4% of cases with an epidural and 4.3% of cases without. (Table 
1) The neonatal composite serious outcome occurred in 4.3% and 3.2% of nulliparous and 
2.7% and 2.2% of multiparous women with and without an epidural, respectively.
The empirical rates for mode of birth and maternal or neonatal morbidity or mortality for 
deliveries that occurred during each 0.5-hour interval of the second-stage duration are 
presented in Figure 1. Vaginal delivery rates were overall high, although decreased with 
increasing second-stage duration, a trend that was more variable for multiparous women. 
Neonatal morbidity or mortality rates increased and then levelled off for deliveries at > 4.0 
to 4.5 hours for nulliparous women with an epidural. Each of the individual morbidity rates 
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also tended to increase with increasing second-stage duration for nulliparous women without 
an epidural, indicating that the composite morbidity was not driven by any individual 
morbidity in particular (data not shown).
Neonatal morbidity or mortality rates varied with increasing duration for nulliparous women 
without an epidural and for multiparous women.
We considered three exclusive outcomes during the second stage of labor. The percentages 
of women delivering by spontaneous vaginal birth without serious morbidity or mortality 
versus the percentages of women delivering by any mode with any serious morbidity or 
mortality in the next 0.5-hour interval among all the women that have not delivered at a 
given time point are presented in Table 2. Rates of spontaneous vaginal birth without 
morbidity were slightly higher after the first half hour (>0.5 to 1.0 hour) for nulliparous 
women, after which rates decreased with increasing second-stage duration. For multiparous 
women, rates of spontaneous vaginal birth without morbidity decreased with increasing 
second-stage duration. The rates of births with a composite maternal or neonatal morbidity 
or mortality were variable with increasing second-stage duration, but not inconsequential 
ranging up to 5.6% for birth after >4.0 to 4.5 hours of second stage duration for nulliparous 
women with an epidural, and 5.3% for birth after >4.5 to 5.0 hours for nulliparous women 
without an epidural. For example, for nulliparous women with an epidural, given that a 
woman had not delivered in 3 hours, her likelihood of delivering with any serious morbidity 
or mortality in the next half hour was 4.4% compared to her likelihood of delivering by 
spontaneous vaginal birth without serious morbidity or mortality was 19.5%. For 
multiparous women, the percentages of births with morbidity were more varied, with the 
highest percentages in the first half hour of second stage (0 to 0.5 hours), and peaking again 
at 4.8% for birth after >4.0 to 4.5 hours of second stage duration for multiparous women 
with an epidural, and 5.0% for birth after >5.5 to 6.0 hours for multiparous women without 
an epidural.
Ranges of intervals are also provided in Table 3. For example, for nulliparous women with 
an epidural, given that a woman had not delivered in 3 hours, her likelihood of delivering 
with any serious morbidity or mortality in one hour beyond historical definitions of second-
stage duration (>3.0 to 4.0 hours) was 7.6% compared to her likelihood of delivering by 
spontaneous vaginal birth without serious morbidity or mortality of 31.4%. The rates for the 
previous hour (>2.0 to 3.0 hours) were 6.9% and 37.5%, respectively.
Indications for cesarean birth were calculated for extending the second stage of labor by one 
hour past historical definitions of second-stage duration for parity and epidural status. (Table 
4) The percent of cesarean births for non-reassuring fetal heart rate tracing for women 
without versus with an epidural were higher.
Discussion
Spontaneous vaginal birth without morbidity was slightly higher after the first half hour 
(>0.5 to 1.0 hour) for nulliparous women, after which rates decreased with increasing 
second-stage duration, while rates steadily declined for multiparous women.. To assist in 
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weighing the likelihood of vaginal birth against the risk of serious maternal or neonatal 
morbidity or mortality, we provide data on both the risks and likelihood of spontaneous 
vaginal birth without serious morbidity or mortality versus the percentages of women 
delivering by any mode with any serious morbidity or mortality for increasing the duration 
of second stage.
Our findings are somewhat difficult to put into the context of the literature since modeling 
the outcomes of delivery and morbidity or mortality jointly in a competing risks framework 
in the same model is novel. In addition, many prior studies were limited in their ability to 
study rare serious morbidity and mortality given fewer numbers. The recommendations for 
point at which to stop a second stage has changed over the recent years. Historically, 
maternal and neonatal risks have been considered to increase with a second stage beyond 
two hours and have been described with increasing duration in other studies.(3, 4, 8–16) 
Operative vaginal birth historically was considered as an option in cases with lack of 
continuing progress for two hours without regional anesthesia in nulliparous women and one 
hour in multiparous women, with allowance for an additional hour with regional anesthesia, 
in an older ACOG practice bulletin on operative vaginal birth from 2000 which since has 
been replaced in 2015 without mention of specific duration.(17) ACOG and SMFM have 
published an obstetric care consensus document acknowledging that while an absolute 
maximum duration of second stage is unknown, the diagnosis of second stage arrest should 
not be made until as at least three hours of pushing in nulliparous women and two hours of 
pushing in multiparous women, and allowing consideration of longer durations in women 
making progress to be determined on an individual basis.(18) These recommendations note 
the importance of progress with pushing which is distinct from whether active versus passive 
second stage may be associated with differences in maternal and neonatal outcomes and 
requires future study. In our study, we did not observe an inflection at a particular hour 
mark. The percentage of women having a spontaneous vaginal birth without serious 
maternal or neonatal morbidity steadily decreased regardless of parity or epidural status for 
increasing second-stage duration (except for the first half hour for nulliparous women), 
while the percentage of deliveries by any mode with a serious morbidity were variable but 
not inconsequential. Ultimately the willingness to accept a certain percent risk of morbidity 
to achieve vaginal birth is up to the woman and clinician.
The major strength of our study is the large numbers and multiple centers allowing 
investigation of rare serious morbidity and mortality. However, our study is limited by the 
retrospective nature of the data. The decision making for women who were allowed to have 
longer second-stage durations likely was complex and may have included a number of 
factors such as progression, maternal and neonatal status, clinician experience and the 
clinician-patient relationship. It is unclear how the interplay of these factors could have 
influenced the success of vaginal birth and rate of adverse outcomes. In addition, we did not 
have information on active versus delayed pushing. The generalizability of our findings 
might be slightly less given the increasing obesity in the United States since the original data 
collection. Data on long term maternal morbidity including incontinence and child 
neurological outcomes are also lacking.
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Data to assist in decision making for extending the second stage of labor beyond the 
historical definitions of second-stage duration is limited. Additional factors such as progress 
in descent, station achieved, position of the head, estimated fetal weight, maternal fatigue, 
the presence of chorioamnionitis or meconium, and fetal heart tracing, are important to take 
into account when deciding on the length of the second stage for any individual patient. 
While we cannot make a recommendation for the optimal second-stage duration, our 
findings will assist clinicians and patients in the decision for weighing the likelihood of 
spontaneous vaginal birth with the risk of serious maternal and neonatal morbidity or 
mortality when considering continuing the duration of second stage.
Supplementary Material
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Figure 1. 
Empirical rates of birth mode and morbidity or mortality. Nulliparous women with epidural 
(A–B), nulliparous women without epidural (C–D), multiparous women with epidural (E–
F), and multiparous women without epidural (G–H). Rates per 0.5 hour interval for mode of 
birth (spontaneous vaginal birth, operative vaginal birth, or cesarean birth); composite 
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serious maternal morbidity or mortality including postpartum hemorrhage, blood 
transfusion, cesarean hysterectomy, intensive care unit admission, or death; and composite 
serious neonatal morbidity or mortality including shoulder dystocia with fetal injury 
(clavicular fracture, Erb palsy, Klumpke palsy or hypoxic-ischemic encephalopathy), need 
for continuous positive airway pressure resuscitation or higher, neonatal intensive care unit 
length of stay >72 hours, sepsis, pneumonia, hypoxic-ischemic encephalopathy or 
periventricular leukomalacia, seizure, intracranial hemorrhage or periventricular 
hemorrhage, asphyxia, or neonatal death.
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Table 1
Duration of second stage of labor and outcomes by parity and epidural status.
Nulliparous With 
Epidural
35657 (81.4%)*
Nulliparous 
Without Epidural
8153 (18.6%)*
Multiparous With 
Epidural
43436 (72.9%)*
Multiparous 
Without Epidural
16169 (27.1%)*
Duration, hours - median (10th, 90th 
percentile)
1.1 (0.3,3.0) 0.7 (0.2,2.4) 0.3 (0.1,1.1) 0.2 (0.03,0.7)
Maternal Morbidity or Death
Maternal Composite † 2,481 (7%) 410 (5%) 2,765 (6.4%) 691 (4.3%)
 Postpartum hemorrhage 1,410 (4%) 329 (4%) 1,030 (2.4%) 459 (2.8%)
 Blood transfusion 1,102 (3.1%) 85 (1%) 1,715 (3.9%) 231 (1.4%)
 Cesarean hysterectomy 8 (0.02%) 2 (0.02%) 11 (0.03%) 3 (0.02%)
 ICU admission 119 (0.3%) 11 (0.1%) 117 (0.3%) 37 (0.2%)
 Maternal death 2 (0.006%) 0 2 (0.005%) 0
Neonatal Morbidity or Death
Neonatal Composite ‡ 1,523 (4.3%) 262 (3.2%) 1155 (2.7%) 353 (2.2%)
 Shoulder dystocia with 30 (0.1%) 7 (0.1%) 29 (0.1%) 8 (0.05%)
 fetal injury §
 Need for CPAP 366 (1%) 39 (0.5%) 264 (0.6%) 67 (0.4%)
 resuscitation or higher
 NICU length of stay > 72 hours 864 (2.4%) 130 (1.6%) 705 (1.6%) 199 (1.2%)
 Sepsis 487 (1.4%) 96 (1.2%) 287 (0.7%) 120 (0.7%)
 Pneumonia 255 (0.7%) 39 (0.5%) 198 (0.5%) 51 (0.3%)
 Hypoxic-ischemic encephalopathy or 
periventricular leukomalacia
5 (0.01%) 2 (0.02%) 1 (0.002%) 0
 Seizure 39 (0.1%) 4 (0.05%) 17 (0.04%) 8 (0.05%)
 Intracranial hemorrhage or 
periventricular hemorrhage
56 (0.2%) 7 (0.1%) 34 (0.1%) 4 (0.02%)
 Asphyxia 58 (0.2%) 12 (0.1%) 41 (0.1%) 11 (0.1%)
 Neonatal death 9 (0.03%) 4 (0.05%) 10 (0.02%) 6 (0.04%)
Route of Delivery
 Spontaneous vaginal birth 29529 (82.8%) 7349 (90.1%) 41421 (95.4%) 15855 (98.1%)
 Operative vaginal birth 4748 (13.3%) 613 (7.5%) 1742 (4.0%) 261 (1.6%)
 Cesarean birth 1380 (3.9%) 191 (2.3%) 273 (0.6%) 53 (0.3%)
Abbreviations: ICU, intensive care unit; CPAP, Continuous positive airway pressure; NICU, neonatal intensive care unit
*
Data are n (%) except where noted.
†
Maternal composite includes all individual maternal outcomes listed below.
‡Neonatal composite includes all individual neonatal outcomes listed below.
§
Fetal injury included clavicular fracture, Erb’s palsy, Klumpke’s palsy or hypoxic-ischemic encephalopathy
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Table 4
Indications for cesarean birth in one hour beyond historical definitions of second-stage duration by parity and 
epidural status*
Nulliparous With 
Epidural >3.0 to 4.0 
hours (n=270)
Nulliparous Without 
Epidural >2.0 to 3.0 
hours (n=38)
Multiparous With 
Epidural >2.0 to 3.0 
hours (n=65)
Multiparous Without 
Epidural >1.0 to 2.0 
hours (n=5)
Failure to progress or 
CPD b 227 (84.1%) 29 (76.3%) 46 (70.8%) 1 (20.0%)
Non-reassuring fetal heart 
rate tracing c 24 (8.9%) 8 (21.1%) 9 (13.8%) 4 (80.0%)
Other 31 (11.5%) 6 (15.8%) 13 (20.0%) 2 (40.0%)
Abbreviations: CPD, cephalopelvic disproportion
*Since more than one indication could have been listed, indications add up to > 100%.
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